‌

US Patent 8865211 Bioadhesive drug formulations for oral transmucosal delivery

Patent 8865211 was granted and assigned to Talphera on October, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Pamela Palmer0

Andrew I. Poutiatine0

Larry Hamel0

Stelios Tzannis0

Thomas Schreck0

Date of Patent

October 21, 2014

0

Patent Application Number

135958790

Date Filed

August 27, 2012

0

Patent Citations Received

US Patent 12005085 Probiotic method and composition for maintaining a healthy vaginal microbiome

0

US Patent 11998574 Method and system for modulating an individual's skin microbiome

0

US Patent 11672738 Apparatus and methods for dispensing oral transmucosal dosage forms

0

US Patent 11676691 Storage and dispensing devices for administration of oral transmucosal dosage forms

0

US Patent 11998479 Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure

0

US Patent 11839632 Topical application of CRISPR-modified bacteria to treat acne vulgaris

0

US Patent 11833177 Probiotic to enhance an individual's skin microbiome

0

US Patent 11951139 Method and system for reducing the likelihood of osteoporosis

0

...

Patent Primary Examiner

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8865211 Bioadhesive drug formulations for oral transmucosal delivery

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.